Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glucosamine/neoplasms

Länken sparas på Urklipp
9 resultat

Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application is the National Phase of PCT/KR2006/005229 filed on Dec. 6, 2006, which claims priority under 35 U.S.C. 119(a) to Patent Application Nos. 10-2006-0054519 and 10-2006-0119620 filed in Republic of Korea on Jun. 16, 2006 and Nov. 30, 2006, respectively. All of the above applications
TECHNICAL FIELD The present invention relates to the use of N-acetyl-D-glucosamine and pharmaceutical acceptable salts thereof in the manufacture of a medicament for inhibiting the side effect of radio-chemical therapy. BACKGROUND ART After accepting radio-chemical treatment, patients with neoplasm

Dietary supplement formulation for controlling inflammation and cancer

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin. BACKGROUND OF THE

N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Background of the Invention The present invention relates to acyl derivatives of glucosamines with amino acids or synthetic peptides, endowed with antitumor chemotherapeutic activity against transplanted tumors in animals, to pharmaceutical compositions containing said derivatives, to processes for

Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to specific glucosamine disaccharides, in particular to 2-N- and/or 2'-N-acylated glucosamine disaccharides, wherein at least one of the acyl groups is branched, and to compounds comprising these disaccharides. The present invention relates further to methods for

Composition for treating hormonally-dependent cancers

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary

N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION The present invention relates to N-acyl derivatives of an amino sugar with an oligopeptide, endowed with antitumor chemotherapeutic activity, and to pharmaceutical compositions containing said derivatives. Antitumor chemotherapy has been and still is an object of

Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This is a national-phase application of Int'l Appln. No. PCT/JP03/17030 under 35 U.S.C. 371, filed Dec. 26, 2003; the entire content of which is hereby incorporated by reference in this application. TECHNICAL FIELD The present invention relates to a novel nucleic acid, the nucleic acid for testing

Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This invention relates to methods for discovering agonists and antagonists of the interaction between UDP-sugars (e.g.,UDP-glucose, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetyl glucosamine) and their cellular receptor, human KIAA0001 receptor. The invention also
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge